Chesapeake's stock being up at all is a meaningful accomplishment.
Investors need to curb their enthusiasm and not set unrealistic expectations for this company.
ARM has answered Wall Street's call for growth in a big way. But it's risky to think it can keep that going.
JPMorgan still has a strong business in investment banking, mortgages and retail banking, but investors are still hanging back.
This health-care products producer is no longer sneaking up on anyone.
Exxon's shares are not going to excite investors with strong upswings, but there is little to no downside risk.
It's finally time for investors to cut their losses and move on.
If Schlumberger can trade at 10 times forward EBITDA, the stock can reach $90 per share. Who wouldn't take a 20% to 25% premium?
There's still plenty of work left to be done but there are signs the bank is slowly regaining investor and consumer confidence.
On the basis of its first-quarter performance, this stock is worth at least 20% higher than current value.